Granite Point Capital Management’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-66,666
| Closed | -$2K | – | 96 |
|
|
2022
Q4 | $2K | Hold |
66,666
| – | – | ﹤0.01% | 77 |
|
|
2022
Q3 | $5K | Hold |
66,666
| – | – | ﹤0.01% | 91 |
|
|
2022
Q2 | $10K | Hold |
66,666
| – | – | ﹤0.01% | 96 |
|
|
2022
Q1 | $20K | Hold |
66,666
| – | – | ﹤0.01% | 109 |
|
|
2021
Q4 | $34K | Hold |
66,666
| – | – | 0.01% | 105 |
|
|
2021
Q3 | $37K | Hold |
66,666
| – | – | ﹤0.01% | 113 |
|
|
2021
Q2 | $67K | Buy |
+66,666
| New | +$67K | ﹤0.01% | 131 |
|